As we navigate through flu season and the ongoing challenges of respiratory illnesses, it’s crucial to prioritize our health and well-being. One of the most effective ways to do this ...

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

RSV infection that is managed via primary care in children under 5 years of age leads to a substantial burden for families, primary care resources, and society.

Moderna (MRNA) reported mixed fourth quarter earnings and full-year 2024 earnings Friday. Moderna's stock was down 5% in premarket trading on the earnings results but rose more than 2% sharply after ...

Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...

Moderna (MRNA) reported mixed fourth quarter earnings, and full year 2024 earnings compared to Wall Street expectations Friday. Moderna's stock was down 4.5% in pre-market trading on the earnings ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced President Donald Trump's ...

Respiratory syncytial virus (RSV) is known to cause considerable respiratory infection-related morbidity and mortality worldwide.1,2 Estimates published in 2022 from the UK highlight the ...

Early signs of whooping cough in adults look very much like a common cold, Dr. Loafman says. For the first week or so of ...

The recent surge in influenza cases in the Triad and statewide has led to an increase in flu-related deaths, including two ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...